Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Immuneering (IMRX) Receivables - Net (2020 - 2023)

Immuneering has reported Receivables - Net over the past 4 years, most recently at $1046.0 for Q1 2023.

  • Quarterly results put Receivables - Net at $1046.0 for Q1 2023, down 99.63% from a year ago — trailing twelve months through Mar 2023 was $1046.0 (down 99.63% YoY), and the annual figure for FY2022 was $12417.0, down 94.95%.
  • Receivables - Net for Q1 2023 was $1046.0 at Immuneering, down from $12417.0 in the prior quarter.
  • Over the last five years, Receivables - Net for IMRX hit a ceiling of $500110.0 in Q4 2020 and a floor of $1046.0 in Q1 2023.
  • Median Receivables - Net over the past 4 years was $246040.0 (2021), compared with a mean of $250479.1.
  • Biggest five-year swings in Receivables - Net: plummeted 50.8% in 2021 and later plummeted 99.63% in 2023.
  • Immuneering's Receivables - Net stood at $500110.0 in 2020, then plummeted by 50.8% to $246040.0 in 2021, then crashed by 94.95% to $12417.0 in 2022, then crashed by 91.58% to $1046.0 in 2023.
  • The last three reported values for Receivables - Net were $1046.0 (Q1 2023), $12417.0 (Q4 2022), and $70180.0 (Q3 2022) per Business Quant data.